Group 1 - The core announcement is that Kelun Pharmaceutical has had five products included in the National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug List for 2025 [2] - The announcement was made on the evening of December 8, indicating the company's proactive communication regarding its product portfolio [2] - The inclusion in the drug list is a significant development for the company, potentially enhancing its market access and revenue opportunities [2] Group 2 - The announcement was made by the National Healthcare Security Administration and the Ministry of Human Resources and Social Security [2] - The notification regarding the drug list was officially published on December 7, 2025 [2] - This inclusion reflects the government's ongoing efforts to expand access to essential medications for the population [2]
科伦药业:关于公司药品纳入国家医保目录的公告